8 Coupons
-
Special Offer
-
30% off
connect with kpcc
-
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.rewards
-
.
- .
-
.
.
.please wait�
related topics
-
.